Newsletter No. 104 -- June 2008
EXPLORATORY COLLABORATIONS WITH NATIONAL CENTERS FOR BIOMEDICAL COMPUTING (R21) (PAR-08-183)
COLLABORATIONS WITH NATIONAL CENTERS FOR BIOMEDICAL COMPUTING (R01) (PAR-08-184) (NCI, MULTIPLE INSTITUTES)
Application Due Date(s): Standard dates apply
This funding is for projects from individual-investigators or small groups to collaborate with the NIH Roadmap for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.bisti.nih.gov/ncbc/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones.
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PAR-08-183.html
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PAR-08-184.html
PEDIATRIC BRAIN TUMOR CONSORTIUM (U01) (NCI, NINDS)
Letters of Intent Receipt Date: July 15, 2008
Application Receipt Date: August 15, 2008
The purpose of this open competition Funding Opportunity Announcement (FOA) is to stimulate the translation of innovative therapies suitable for children with brain tumors from the laboratory to early phase clinical testing. To achieve this goal, the National Cancer Institute (NCI) intends to continue a Pediatric Brain Tumor Consortium (PBTC) program. The NCI will support one multi-center clinical trials group (a "Consortium") that will be responsible for timely conduct of the Phase 1, Phase 2, and pilot studies evaluating novel treatment approaches relevant to the pediatric brain tumor population. NINDS will be involved in coordinating PBTC activities across other NIH-supported normal and disease-oriented brain imaging Networks (including the NCI-supported adult brain tumor consortium) as well as in aspects related to the neurocognitive, quality-of-life impact of certain treatments on long-term survivors of pediatric brain tumors.
CONTINUATION, EXPANSION AND MERGING OF THE BILIARY ATRESIA RESEARCH CONSORTIUM (BARC) AND THE CHOLESTATIC LIVER CONSORTIUM (CLIC) TO FORM THE CHILDHOOD LIVER DISEASE RESEARCH AND EDUCATION NETWORK (CHILDREN) (U01) (NIDDK, NICHD)
Letters of Intent Receipt Date: October 24, 2008
Application Receipt Date: November 25, 2008
The major objective of the newly formed ChiLDREN would be to combine the expertise and resources of the BARC and CLiC clinical centers and expand to up to 15 clinical centers and to establish one data coordinating center to study pediatric liver diseases. All functions and resources of both the BARC and the CLiC, including continued participation in the RDCRN, and the expansion to 15 clinical centers would enhance the ability and efficiency of the ChiLDReN to enroll sufficient numbers of children into the ongoing longitudinal studies and clinical trials. ChiLDREN would thus facilitate the ability of the network to discover new diagnostics, etiologic, and treatment options for children with liver disease and those who undergo liver transplantation and to train the next generation of investigators in rare pediatric liver diseases. Among the specific objectives of the newly formed ChiLDREN is "identification and validation of non-invasive markers of liver disease in CF patients including but not limited to new imaging modalities."
CLINICAL CENTERS FOR THE NHLBI ASTHMA NETWORK (ASTHMANET) (U10) (NHLBI)
Letters of Intent Receipt Date: December 30, 2008
Application Receipt Date: January 30, 2009
This announcement invites applications to participate in the NHLBI Asthma Network (AsthmaNet), a clinical research network that will develop and conduct multiple clinical trials to address the most important asthma management questions and new treatment approaches in pediatric and adult populations. Examples of mechanistic study topics related to AsthmaNet's secondary research aims include evaluation of predictors of response to treatment; examination of the role of imaging to assess disease progression and treatment response; and profiling molecular and cellular events that regulate disease progression or modify treatment response.
SILVIO O. CONTE CENTERS FOR BASIC AND TRANSLATIONAL MENTAL HEALTH RESEARCH (P50) (PAR-08-194) (NIMH)
Letters of Intent Receipt Date(s): August 25, 2008, August 25, 2009, August 25, 2010
Application Receipt Date(s): September 23, 2008, September 23, 2009, September 23, 2010
Cores should support the proposed objectives of the Conte Center and should support multiple projects as well as the overall goals of the Center. An administrative Core is required. Additional Cores may be proposed for animal support, biostatistics and data management, imaging, chemistry, etc and should be well justified based on the needs of the Center's research projects.
RESEARCH SUPPLEMENTS TO PROMOTE DIVERSITY IN HEALTH-RELATED RESEARCH (PA-08-190)
Application Receipt Date(s): Multiple dates, see announcement.
You may submit (an) application(s) if you are the Principal Investigator, at a domestic institution, who holds an active R00, R01 (or RL1), R10, R18, R22, R24, R35, R37, R43, R44, R41, R42, DP1, DP2, P01 (or PL1), P20, P30, P40, P41, P50, P51, P60, U01 (or UL1), U10, U19, U41, U42, U54. Because policies may vary among awarding components regarding eligibility of Small Grant Awards (R03), Academic Research Enhancement Awards (R15), Support of Continuous Research Excellence (SC1, SC2, SC3), or Exploratory/Developmental Grants (R21) for supplements under this program, grantees holding those awards must check with the appropriate awarding component before submitting an application for a supplement.
RESEARCH SUPPLEMENTS TO PROMOTE RE-ENTRY INTO BIOMEDICAL AND BEHAVIORAL RESEARCH CAREERS (PA-08-191)
Application Receipt Date(s): Multiple dates, see announcement.
The purpose of these supplements is to encourage such individuals to re-enter research careers within the missions of all the program areas of NIH. This program will provide administrative supplements to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals in a program geared to bring their existing research skills and knowledge up to date. You may submit (an) application(s) if you are the Principal Investigator, at a domestic institution, who holds an active R01 (RL1), R10, R18, R22, R24, R35, R37, R41, R42, R43, R44, DP1, DP2, P01 (PL1), P20, P30, P40, P41, P50, P51, P60, U01 (Ul1), U10, U19, U41, U42, and/or U54.
SOCIETY OF IMAGING INFORMATICS IN MEDICINE (SIIM) 2009 GRANTS
Application Deadline: August 1, 2008
SIIM offers two $50,000 grants for one year to support original hypothesis-driven research in the field of imaging informatics for residents, fellows, graduate students, and junior faculty. The expanded SIIM Grant Program includes four additional grant initiatives: a small grant for imaging informatics training, a small grant for product support development, an emeritus mentor grant, and a micro grant. The SIIM Grant Program emphasizes an increased commitment to supporting and expanding imaging informatics research.
CIP DCIDE PROGRAM The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at firstname.lastname@example.org. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
Request for Information (RFI): Emerging Capabilities for Non-Invasive Imaging of Brain Structure and Function (Neuroscience Blueprint) ( NOT-AG-08-005) (multiple Institutes)
Please send responses to email@example.com no later than August 1, 2008.
This is a time-sensitive RFI directed toward determining how best to accelerate research in non-invasive imaging of human brain structure and function. Responses to this RFI should be pertinent to the interests of one or more of the NIH Neuroscience Blueprint Institutes listed in the announcement. Comments pertaining to emerging capabilities and technologies related to human brain imaging, from molecular imaging to neural connectivity imaging, are encouraged.
Rapid Access to Intervention Development (RAID) (NOT-CA-08-024) (NCI)
Application deadlines: There are two windows of opportunity per year to file requests for RAID support. Please see the announcement for details.
The RAID Program makes available to academic investigators the preclinical development resources managed by the NCI's Developmental Therapeutics Program (DTP). Access to these resources is granted on a competitive basis following the evaluation of submitted project proposals by an external review committee. However, RAID is not a grant program.
NIH Policy on Submission of Additional Grant Application Materials
NIH Extramural Loan Repayment Programs
Notice contains links to various repayment programs. Several of the programs are institute-specific.
NIH Implementation of Government-wide Standard Terms and Conditions for Research Grants
Transforming Medicine Through Innovation: 10th Annual NIH SBIR/STTR Conference
July 22-23, 2008
50th AAPM Annual Meeting
July 27-31, 2008, George R Brown Convention Center, Houston, TX
World Molecular Imaging Congress
Sponsored by the Society for Molecular Imaging (SMI), the Academy of Molecular Imaging (AMI), the European Society for Molecular Imaging (ESMI) and the Federation of Asian Societies for Molecular Imaging (FASMI)
September 10-13, 2008, Nice, France
ISMRM Workshop on Frontiers of Magnetic Resonance: From Tumor Cell to Cancer Patient
September 13-16, 2008, Nice, France
First International MR Focused Ultrasound Surgery Symposium
October 6-7, 2008, Washington, DC
Seventh International Conference on the Ultrasonic Measurement and Imaging of Tissue Elasticity
October 27-30, 2008, The Lakeway Resort and Spa, Lake Travis, Austin, TX
4th Annual Small Animal Imaging Workshop
November 5-8, 2008, Clark Auditorium, Stanford University
5th Annual Memphis BioImaging Conference
November 6-7, 2008, Fogelman Executive Conference Center, Memphis, TN
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program,
Division of Cancer Treatment and Diagnosis,
NCI 6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507